Remove Ethics Remove Government Remove Networking
article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Companies are invited to reapply each year to be evaluated based on how their policies, actions, and results are impacting the environment, ethics, labor and human rights, and sustainable procurement. And last, but certainly not least—governance. Ethics is a skill.” Why make it inviting? What’s Next? Track, measure, and improve.

Pharma 103
article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Ethical Challenges for Pharmaceutical Marketers in Using AI to Write Marketing Copy or Creative

Pharma Marketing Network

While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination. “The ethics of artificial intelligence.”

Ethics 52
article thumbnail

Leveraging Influencer Networks in Pharma Marketing: Strategies for Building Trust and Engagement

Pharma Marketing Network

By leveraging influencer networks, pharmaceutical brands can effectively convey their messages, promote their products, and ultimately improve patient outcomes. The potential of influencer networks in pharma marketing lies in their ability to bridge the gap between pharmaceutical companies and their target audiences.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic. The significant challenges, here, lie in effectively managing the complexity and coordination among diverse interconnected networks, particularly when operating across countries with varying regulations.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

Resource Constraints: The FDA operates within a dynamic regulatory environment and faces resource constraints like any other government agency. appeared first on Pharma Marketing Network. The post Why Is FDA Issuing Fewer Marketing Violation Letters?

article thumbnail

How to write a peer review: practical templates, expert examples, and free training courses

Clarivate

It will also help you identify potential breaches of normal ethical practice. You can attend in-person workshops to learn from and network with experienced reviewers and editors. Ethical guidelines for peer review from COPE. EQUATOR Network’s reporting guidelines for health researchers. Are we missing anything?